SINEX SCENT FREE ULTRA FINE MIST 0.05 %
OXYMETAZOLINE HYDROCHLORIDE : 0.05 % · DIN 02456486 · PROCTER & GAMBLE INC
Health Canada status: CANCELLED PRE MARKET
What is SINEX SCENT FREE ULTRA FINE MIST?
SINEX SCENT FREE ULTRA FINE MIST 0.05 % contains OXYMETAZOLINE HYDROCHLORIDE : 0.05 %. It is listed in the Health Canada Drug Product Database under DIN 02456486, held by PROCTER & GAMBLE INC, supplied as SPRAY for NASAL administration. Health Canada currently lists it as cancelled pre market, status dated 21-May-2021. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02456486 |
|---|---|
| Brand name | SINEX SCENT FREE ULTRA FINE MIST |
| Generic / active ingredient | OXYMETAZOLINE HYDROCHLORIDE : 0.05 % |
| Manufacturer | PROCTER & GAMBLE INC |
| Strength | 0.05 % |
| Dosage form | SPRAY |
| Route of administration | NASAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | R01AA05 OXYMETAZOLINE |
| AHFS class | 52:32.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED PRE MARKET |
| Status date | 21-May-2021 |
What can be used instead?
Other Canadian products sharing ATC code R01AA05 OXYMETAZOLINE. 13 of 42 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLARITIN ALLERGY DECONGESTANT | 0.05 % | SOLUTION | BAYER INC | MARKETED | DIN 02243690 |
| DRIXORAL DECONGESTANT NASAL SPRAY | 0.05 % | SOLUTION | BAYER INC | MARKETED | DIN 00740861 |
| DRIXORAL NASAL CONGESTION | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02380129 |
| DRIXORAL NO DRIP COOLING MENTHOL | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02245580 |
| DRIXORAL NO DRIP EXTRA MOISTURIZING | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02245575 |
| DRIXORAL NO DRIP NASAL CONGESTION | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02498294 |
| DRIXORAL NO DRIP NASAL CONGESTION WITH MENTHOL | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02498308 |
| DRIXORAL NO DRIP ORIGINAL UNSCENTED | 0.05 % | SPRAY | BAYER INC | MARKETED | DIN 02245578 |
| EXTRA MOISTURIZING NASAL SPRAY | 0.05 % | SPRAY, METERED DOSE | JUNO OTC INC | MARKETED | DIN 02460572 |
| LONG LASTING DECONGESTANT NASAL SPRAY | 0.05 % | SPRAY | CRLS | MARKETED | DIN 02454351 |
Who else supplies OXYMETAZOLINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OXYMETAZOLINE appears in 56 registered pack listings across 5 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.